Cargando…

Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer

Breast cancer is the most prevalent type of malignancy in women worldwide. Taxanes (paclitaxel and docetaxel) are widely applied as first-line chemotherapeutic agents, while the therapeutic effect is seriously limited by the development of drug resistance. In the present study, we screened out sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Danni, Bao, Chang, Zhao, Feng, Yu, Haogang, Zhong, Guansheng, Xu, Liang, Yan, Senxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473300/
https://www.ncbi.nlm.nih.gov/pubmed/32974144
http://dx.doi.org/10.3389/fonc.2020.01397
_version_ 1783579157649686528
author Chen, Danni
Bao, Chang
Zhao, Feng
Yu, Haogang
Zhong, Guansheng
Xu, Liang
Yan, Senxiang
author_facet Chen, Danni
Bao, Chang
Zhao, Feng
Yu, Haogang
Zhong, Guansheng
Xu, Liang
Yan, Senxiang
author_sort Chen, Danni
collection PubMed
description Breast cancer is the most prevalent type of malignancy in women worldwide. Taxanes (paclitaxel and docetaxel) are widely applied as first-line chemotherapeutic agents, while the therapeutic effect is seriously limited by the development of drug resistance. In the present study, we screened out several miRNAs dysregulated in taxanes-resistant breast cancer samples and confirmed that two miRNAs (miR-335-5p and let-7c-5p) played a major role in cell proliferation, apoptosis, and chemo-resistance. In addition, the weighted gene co-expression network analysis (WGCNA) for potential target genes of miR-335-5p and let-7c-5p identified three hub genes (CXCL9, CCR7, and SOCS1) with a positive relationship to taxanes-sensitivity. Further, target relationships between miR-335-5p and CXCL9, let-7c-5p and CCR7/SOCS1 were confirmed by dual-luciferase reporter assays. Importantly, the regulatory functions of CXCL9, CCR7, and SOCS1 on proliferation and chemoresistance were validated. In conclusion, our study shed light on clinical theragnostic relationships between miR-335-5p/CXCL9, let-7c-5p/CCR7/SOCS1 axes, and taxanes-resistance in breast cancer.
format Online
Article
Text
id pubmed-7473300
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74733002020-09-23 Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer Chen, Danni Bao, Chang Zhao, Feng Yu, Haogang Zhong, Guansheng Xu, Liang Yan, Senxiang Front Oncol Oncology Breast cancer is the most prevalent type of malignancy in women worldwide. Taxanes (paclitaxel and docetaxel) are widely applied as first-line chemotherapeutic agents, while the therapeutic effect is seriously limited by the development of drug resistance. In the present study, we screened out several miRNAs dysregulated in taxanes-resistant breast cancer samples and confirmed that two miRNAs (miR-335-5p and let-7c-5p) played a major role in cell proliferation, apoptosis, and chemo-resistance. In addition, the weighted gene co-expression network analysis (WGCNA) for potential target genes of miR-335-5p and let-7c-5p identified three hub genes (CXCL9, CCR7, and SOCS1) with a positive relationship to taxanes-sensitivity. Further, target relationships between miR-335-5p and CXCL9, let-7c-5p and CCR7/SOCS1 were confirmed by dual-luciferase reporter assays. Importantly, the regulatory functions of CXCL9, CCR7, and SOCS1 on proliferation and chemoresistance were validated. In conclusion, our study shed light on clinical theragnostic relationships between miR-335-5p/CXCL9, let-7c-5p/CCR7/SOCS1 axes, and taxanes-resistance in breast cancer. Frontiers Media S.A. 2020-08-21 /pmc/articles/PMC7473300/ /pubmed/32974144 http://dx.doi.org/10.3389/fonc.2020.01397 Text en Copyright © 2020 Chen, Bao, Zhao, Yu, Zhong, Xu and Yan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Chen, Danni
Bao, Chang
Zhao, Feng
Yu, Haogang
Zhong, Guansheng
Xu, Liang
Yan, Senxiang
Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer
title Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer
title_full Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer
title_fullStr Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer
title_full_unstemmed Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer
title_short Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer
title_sort exploring specific mirna-mrna axes with relationship to taxanes-resistance in breast cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473300/
https://www.ncbi.nlm.nih.gov/pubmed/32974144
http://dx.doi.org/10.3389/fonc.2020.01397
work_keys_str_mv AT chendanni exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer
AT baochang exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer
AT zhaofeng exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer
AT yuhaogang exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer
AT zhongguansheng exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer
AT xuliang exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer
AT yansenxiang exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer